Cerebrospinal fluid neuropeptides in Alzheimer's disease and vascular dementia

[1]  Alistair Burns,et al.  Observations on the brains of demented old people. B.E. Tomlinson, G. Blessed and M. Roth, Journal of the Neurological Sciences (1970) 11, 205–242; (1968) 7, 331–356 , 1997 .

[2]  K. Blennow,et al.  Heterogeneity of Vascular Dementia: Mechanisms and Subgroups , 1993, Journal of geriatric psychiatry and neurology.

[3]  R. Ekman,et al.  Biosynthesis of corticotropin-releasing hormone in human T-lymphocytes , 1993, Journal of Neuroimmunology.

[4]  S. Hauser,et al.  Increased levels of neuronal thread protein in cerebrospinal fluid of patients with Alzheimer's disease , 1992, Annals of neurology.

[5]  C. Nemeroff,et al.  Cerebrospinal fluid neuropeptides in dementia , 1992, Biological Psychiatry.

[6]  K. Blennow,et al.  Clinical Heterogeneity of Probable Alzheimer's Disease , 1992, Journal of geriatric psychiatry and neurology.

[7]  I. Ferrier,et al.  Neocortical concentrations of neuropeptides in senile dementia of the alzheimer and lewy body type: Comparison with parkinson's disease and severity correlations , 1991, Biological Psychiatry.

[8]  C. Nemeroff.  Neuropeptides and Psychiatric Disorders , 1991 .

[9]  J. Kaye,et al.  Cerebrospinal fluid somatostatin and neuropeptide Y. Concentrations in aging and in dementia of the Alzheimer type with and without extrapyramidal signs. , 1988, Archives of neurology.

[10]  V. Chan‐Palay.  Somatostatin immunoreactive neurons in the human hippocampus and cortex shown by immunogold/silver intensification on vibratome sections: Coexistence with neuropeptide Y neurons, and effects alzheimer‐type dementia , 1987, The Journal of comparative neurology.

[11]  C. Wahlestedt,et al.  Peptide YY-like immunoreactivity in the central nervous system of the rat , 1986, Regulatory Peptides.

[12]  A. Kastin,et al.  Delta-sleep-inducing peptide (DSIP): An update , 1986, Peptides.

[13]  P. Emson,et al.  Decreased somatostatin immunoreactivity but not neuropeptide Y immunoreactivity in cerebral cortex in senile dementia of Alzheimer type , 1986, Neuroscience Letters.

[14]  D. Price,et al.  Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease , 1986, Nature.

[15]  T. Crow,et al.  Dissociation of neuropeptide Y and somatostatin in Parkinson's disease , 1985, Brain Research.

[16]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[17]  M. Malmquist,et al.  Radioimmunoassay of delta sleep-inducing peptide using an iodinated p-hydroxyphenylpropionic acid derivative as tracer , 1983, Regulatory Peptides.

[18]  R. Ekman,et al.  Characterization and application of a radioimmunoassay for β-endorphin using an antiserum with negligible cross-reactivity against β-lipotropin , 1982, Regulatory Peptides.

[19]  R. Katzman.,et al.  Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa , 1980, Nature.

[20]  S. Ohman,et al.  Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. , 1977, Scandinavian journal of clinical and laboratory investigation.

[21]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[22]  K. Blennow,et al.  Concentration gradients for monoamine metabolites in lumbar cerebrospinal fluid , 1993, Journal of neural transmission. Parkinson's disease and dementia section.

[23]  K. Blennow,et al.  Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age. , 1993, European neurology.

[24]  K. Blennow,et al.  Protein Analysis in Cerebrospinal Fluid , 1993 .

[25]  L. Terenius.  Chapter 31 Opioid peptides, pain and stress , 1992 .

[26]  G. Bissette,et al.  Somatostatin in Alzheimer's disease and depression. , 1992, Life sciences.

[27]  L. Minthon,et al.  Neuropeptide levels in Alzheimer's disease and dementia with frontotemporal degeneration. , 1990, Journal of neural transmission. Supplementum.

[28]  E. Sinforiani,et al.  Aging brain and dementias: changes in central opioids. , 1988, European neurology.

[29]  C. Wahlestedt,et al.  Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively. , 1988, Journal of psychiatric research.

[30]  F. Sundler,et al.  Occurrence and distribution of neuropeptides in the human skin. An immunocytochemical and immunochemical study on normal skin and blister fluid from inflamed skin. , 1987, Acta dermato-venereologica.